Condition: COVID-19 SARS-CoV-2 Infection · Sponsor: Pfizer
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospital but who are at high risk for progression to severe disease. Eligible participants will be randomly assigned (by chance) to receive ibuzatrelvir or matching placebo orally for 5 days. Co-administration of locally available standard of care is allowed. The total duration of the study is around 6 months.
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| Applied Research Center of Arkansas | Little Rock, Arkansas, United States | Recruiting |
| National Institute of Clinical Research - Bakersfield | Bakersfield, California, United States | Recruiting |
| Velocity Clinical Research, Huntington Park | Huntington Park, California, United States | Recruiting |
| 310 Clinical Research | Inglewood, California, United States | Recruiting |
| Long Beach Research Institute | Long Beach, California, United States | Recruiting |
| Long Beach Clinical Trials | Long Beach, California, United States | Recruiting |
| Pacific Clinical Studies Inc. | Los Alamitos, California, United States | Recruiting |
| Downtown L.A. Research Center, Inc. | Los Angeles, California, United States | Recruiting |
| Clinica mi Salud by Focil Med | Oxnard, California, United States | Recruiting |
| FOMAT Medical Research | Oxnard, California, United States | Recruiting |
| Paradigm Clinical Research, LLC | Redding, California, United States | Recruiting |
| Acclaim Clinical Research | San Diego, California, United States | Recruiting |
+ 236 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06679140